In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y.

Ynalvez, Leslie A; Deswal, Anita; ACP Journal Club Editorial Team at McMaster University · Ann Intern Med · 2025

Where this comes from

Abstract

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text].